Chronic Stress Promotes Breast Carcinoma Metastasis by Accumulating Myeloid-derived Suppressor Cells Through Activating β-adrenergic Signaling
Overview
Authors
Affiliations
Numerous studies have found that chronic stress could promote tumor progression and this may be related to inhibtion of immune system. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells with immunosuppressive activity. MDSCs may represent a key link between chronic stress and tumor progression. However, the role of stress-induced MDSCs in breast cancer progression is unclear. The present study showed that pre-exposure of chronic stress could lead to MDSCs elevation and facilitated breast cancer metastasis in tumor-bearing mice. Adoptive transfer of MDSCs could significantly increase lung metastatic foci. In contrast, lung metastasis could be alleviated by depleting endogenous MDSCs with Gr-1 antibody. The concentration of norepinephrine in serum and the expression of tyrosine hydroxylase in bone marrow could be significantly elevated by chronic stress. Moreover, propranolol, an inhibitor of β-adrenergic signaling, could inhibit breast carcinoma metastasis and prevent the expansion of chronic stress-induced MDSCs. Further study revealed that the expressions of IL-6 and JAK/STAT3 signaling pathways were upregulated by chronic stress in mice, and this upregulation could be inhibited by propranolol. Blocking the IL-6 signal or inhibiting the activation of the JAK/STAT3 signaling pathway could reduce tumor growth and metastasis by attenuating the accumulation of MDSCs in vivo. Besides, propranolol inhibited the expression of IL-6 in supernatant of 4T1 cells induced by isoproterenol and reduced the proportion of inducible MDSCs in vitro. Taken together, these data indicated that chronic stress may accumulate MDSCs via activation of β-adrenergic signaling and IL-6/STAT3 pathway, thereby promoting breast carcinoma metastasis.
Chen Z, Cao J, Xiao Z, Yang Z, Cheng Y, Duan J Front Pharmacol. 2024; 15:1485885.
PMID: 39720595 PMC: 11666360. DOI: 10.3389/fphar.2024.1485885.
Zhang L, Pan J, Wang M, Yang J, Zhu S, Li L Adv Sci (Weinh). 2024; 12(4):e2310266.
PMID: 39630109 PMC: 11789585. DOI: 10.1002/advs.202310266.
An insight into the role of innate immune cells in breast tumor microenvironment.
Garg S, Rai G, Singh S, Gauba P, Ali J, Dang S Breast Cancer. 2024; 32(1):79-100.
PMID: 39460874 DOI: 10.1007/s12282-024-01645-8.
Dual roles of myeloid-derived suppressor cells in various diseases: a review.
Nepal M, Shah S, Kang K Arch Pharm Res. 2024; 47(7):597-616.
PMID: 39008186 DOI: 10.1007/s12272-024-01504-2.
Stabellini N, Cullen J, Bittencourt M, Moore J, Sutton A, Nain P J Am Heart Assoc. 2024; 13(14):e033295.
PMID: 38979791 PMC: 11292743. DOI: 10.1161/JAHA.123.033295.